A detailed history of Pathstone Holdings, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Pathstone Holdings, LLC holds 4,308 shares of JAZZ stock, worth $542,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,308
Previous 4,241 1.58%
Holding current value
$542,032
Previous $452,000 6.19%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$100.57 - $116.37 $6,738 - $7,796
67 Added 1.58%
4,308 $480,000
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $88,349 - $101,133
850 Added 25.07%
4,241 $452,000
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $41,353 - $47,664
359 Added 11.84%
3,391 $408,000
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $346,436 - $412,352
3,032 New
3,032 $372,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.89B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.